Invivyd, Inc. (IVVD)

2.48 -0.12 (-4.62%) USD  |  NASDAQ  |  Jan 15, 14:34
More

Invivyd Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for IVVD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Relmada Therapeutics, Inc. --
Arcellx, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade